Free Newsletter
Watson recalls one Propafenone HCL lot
Free newsletter via e-mail
Tools
Watson Pharmaceuticals is voluntarily recalling one lot of Propafenone HCL after it discovered that the drug, which is used to irregular heartbeats, may contain more of the active ingredient than it should. The lot in question was shipped to customers between October 15 and November 26, 2008. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: